Contents of exosomes derived from adipose tissue and their regulation on inflammation, tumors, and diabetes DOI Creative Commons
Yanwen Wang, Qingfeng Li, Shuang‐Bai Zhou

et al.

Frontiers in Endocrinology, Journal Year: 2024, Volume and Issue: 15

Published: Aug. 16, 2024

Adipose tissue (AT) serves as an energy-capacitive organ and performs functions involving paracrine- endocrine-mediated regulation via extracellular vesicles (EVs) secretion. Exosomes, a subtype of EVs, contain various bioactive molecules with regulatory effects, such nucleic acids, proteins, lipids. AT-derived exosomes (AT-exos) include derived from cells in AT, including adipocytes, adipose-derived stem (ADSCs), macrophages, endothelial cells. This review aimed to comprehensively evaluate the impacts different AT-exos on physiological pathological processes. The contents adipocyte-derived ADSC-derived are compared simultaneously, highlighting their similarities differences. have been shown exert complex effects local inflammation, tumor dynamics, insulin resistance. Significantly, differences cargoes observed among diabetes patients, obese individuals, healthy individuals. These could be used predict development mellitus therapeutic targets for improving sensitivity glucose tolerance. However, further research is needed elucidate underlying mechanisms potential applications AT-exos.

Language: Английский

Exosomes in Cancer Progression and Therapy Resistance: Molecular Insights and Therapeutic Opportunities DOI Creative Commons
Madita Wandrey, Jadwiga Jabłońska,

Roland H. Stauber

et al.

Life, Journal Year: 2023, Volume and Issue: 13(10), P. 2033 - 2033

Published: Oct. 9, 2023

The development of therapy resistance still represents a major hurdle in treating cancers, leading to impaired treatment success and increased patient morbidity. establishment minimally invasive liquid biopsies is promising approach improving the early diagnosis, as well monitoring, solid tumors. Because their manifold functions tumor microenvironment, tumor-associated small extracellular vesicles, referred exosomes, have become subject intense research. Besides important roles cancer progression, metastasis, immune response, it has been proposed that exosomes also contribute acquisition transfer resistance, mainly by delivering functional proteins RNAs, facilitating export active drugs or functioning decoys. Extensive research focused on understanding molecular mechanisms underlying occurrence translating these into strategies for detection. With this review, we want provide an overview current knowledge about (patho-)biology state-of-the-art methods isolation analysis. Furthermore, highlight role tumorigenesis treatment, where they can function therapeutic agents, biomarkers, and/or targets. By focusing will reveal new paths exploiting diagnosis treatment.

Language: Английский

Citations

26

Biomimetic Nano‐Cancer Stem Cell Scavenger for Inhibition of Breast Cancer Recurrence and Metastasis after FLASH‐Radiotherapy DOI

Meng Suo,

Hanchen Shen, Meng Lyu

et al.

Small, Journal Year: 2024, Volume and Issue: 20(29)

Published: Feb. 17, 2024

Abstract Compared to conventional radiotherapy (RT), FLASH‐RT delivers ultra‐high dose radiation, significantly reducing damage normal tissue while guaranteeing the effect of cancer treatment. However, recurrence and metastasis frequently occur after all RT due existence intractable stem cells (CSCs). To address this, a biomimetic nanoplatform (named TAFL) tumor‐derived exosome fusion liposomes is designed by co‐loading aggregation‐induced emission photothermal agents, TPE‐BBT, anti‐cancer drugs, aspirin, aiming clear CSCs for inhibiting therapy . Aspirin released in TAFL system triggered laser irradiation can induce apoptosis DNA 4T1 CSCs, comprehensively downregulate their stemness phenotype, inhibit sphericity. Furthermore, TPE‐BBT mediated mild‐photothermal alleviate hypoxic tumor microenvironment, repair which further amplifies aspirin against therefore reduces effective making more biologically safe. In vivo experimental results demonstrated that decreased population treatment inhibited therapy. summary, this provides new idea future clinical application

Language: Английский

Citations

14

Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM/PD-L1 signaling DOI Creative Commons
Shengqi Wang, Jing Li,

Shicui Hong

et al.

Journal of Experimental & Clinical Cancer Research, Journal Year: 2024, Volume and Issue: 43(1)

Published: April 23, 2024

Abstract Background Triple-negative breast cancer (TNBC) is the most aggressive subtype of cancer, and chemotherapy still serves as cornerstone treatment functioning by inducing cytotoxic cell death. Notably, emerging evidence suggests that dying cell-released signals may induce progression metastasis modulating surrounding microenvironment. However, underlying molecular mechanisms targeting strategies are yet to be explored. Methods Apoptotic TNBC cells induced paclitaxel or adriamycin were sorted their released extracellular vesicles (EV-dead) isolated from supernatants. Chemokine array analysis was conducted identify crucial molecules in EV-dead. Zebrafish mouse xenograft models used investigate effect EV-dead on vivo. Results It demonstrated phagocytized macrophages promoting infiltration immunosuppressive PD-L1 + TAMs. identified CXCL1 a component activate TAM/PD-L1 signaling. knockdown macrophage depletion significantly inhibited EV-dead-induced growth metastasis. Mechanistic investigations revealed enhanced signaling transcriptionally activating EED-mediated promoter activity. More importantly, TPCA-1 (2-[(aminocarbonyl) amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide) screened promising inhibitor EVs enhance chemosensitivity limit without noticeable toxicities. Conclusions Our results highlight novel signal provide candidate improve prognosis. Graphical abstract

Language: Английский

Citations

11

The functional regulation between extracellular vesicles and the DNA damage responses DOI
Jin‐Yi Han, Kexin Xu, Ting Xu

et al.

Mutation Research/Reviews in Mutation Research, Journal Year: 2025, Volume and Issue: 795, P. 108532 - 108532

Published: Jan. 1, 2025

Language: Английский

Citations

1

Small extracellular vesicles (sEVs) in pancreatic cancer progression and diagnosis DOI

Reaid Hasan,

Zhen Zhao, Yuanke Li

et al.

Journal of Controlled Release, Journal Year: 2025, Volume and Issue: 380, P. 269 - 282

Published: Feb. 6, 2025

Language: Английский

Citations

1

Cuproptosis-Inducing Functional Nanocomposites for Enhanced and Synergistic Cancer Radiotherapy DOI

Tiaoyan Jiang,

Tian-Ying Jia,

Yipengchen Yin

et al.

ACS Nano, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 2, 2025

Radiotherapy is crucial in local cancer management and needs advancements. Tumor cells elevate intracellular copper levels to promote growth resist radiation; thus, targeted delivery mitochondria could enhance radiotherapy by inducing cuproptosis tumor cells. In this study, we engineered a multifunctional nanoliposome complex, termed Lipo-Ele@CuO2, which encapsulates both peroxide (CuO2) the chelator elesclomol, can Cu ions mitochondria. The Lipo-Ele@CuO2 complex induces mitochondria-mediated synergistically enhances efficacy of radiotherapy. CuO2 acts as donor exhibits inherent sensitivity acidic environments. Additionally, it depletes glutathione, thereby sensitizing cuproptosis. Leveraging its pH-responsive properties microenvironment, facilitate controlled release efficiently delivering at sites. combined vitro vivo studies demonstrate that Lipo-Ele@CuO2-based therapy significantly improves antitumor excellent safety profiles, effectively boosting effectiveness Furthermore, metabolomic transcriptomic analyses reveal combination precipitates significant alterations energy metabolism, notably repressing genes related iron-sulfur cluster assembly glycolysis, confirming induction This therapeutic strategy provides viable approach for addressing clinical resistance demonstrates translational potential.

Language: Английский

Citations

1

Combination of Dendrimers and Exosomes: Implications for Biomedical Applications DOI Open Access

You Ji,

Yunqi Guo, Guixiang Zhang

et al.

Macromolecular Bioscience, Journal Year: 2025, Volume and Issue: unknown

Published: March 8, 2025

The rapid development of nanotechnology enables wide exploration biomimetic nanoplatforms, which can combine traditional nanoparticles and bio-derived materials to have a better performance. Exosomes work as messenger between cells specific biomarkers are also involved in the developmental process diseases. Dendrimers with high physical stability unique structure always used carriers for drugs or genes, thereby realizing enhanced delivery precise theranostics. Therefore, it is promising utilize exosomes transmitters packaging dendrimers, thus reducing cytotoxicity dendrimers improving treatment efficiency. Meanwhile, using multifunctional capture detect disease diagnosis potential strategy. Herein, recent progresses combination summarized, related biomedical applications reviewed. Finally, current challenges future perspectives regard this up-and-coming briefly discussed.

Language: Английский

Citations

1

Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications DOI Creative Commons
Moritz Reese, Sameer A. Dhayat

Journal of Hematology & Oncology, Journal Year: 2021, Volume and Issue: 14(1)

Published: Sept. 8, 2021

Abstract Pancreatic cancer has the worst prognosis among common tumors which is attributed to its aggressive phenotype, diagnosis at advanced, inoperable stages, and resistance systemic therapy. Non-coding RNAs (ncRNAs) such as microRNAs, long non-coding RNAs, circular have been established important regulators of gene expression their deregulation implicated in multiple diseases foremost cancer. In tumor microenvironment, can be distributed cells, stromal immune cells via small extracellular vesicles (sEVs), thereby facilitating intercellular communication influencing major hallmarks angiogenesis, evasion system, metastatic dissemination. Furthermore, sEV-ncRNAs shown promising potential liquid biopsies with diagnostic prognostic significance. this review, we summarize role sEVs carriers ncRNAs underlying molecular mechanisms pancreatic Moreover, review biomarkers highlight suitability delivery vehicles for ncRNA-based

Language: Английский

Citations

50

Extracellular vesicles in pancreatic cancer progression and therapies DOI Creative Commons
Chao‐Hui Chang, Siim Pauklin

Cell Death and Disease, Journal Year: 2021, Volume and Issue: 12(11)

Published: Oct. 20, 2021

Abstract Pancreatic cancer (PC) is one of the leading causes cancer-related death worldwide due to delayed diagnosis and limited treatments. More than 90% all pancreatic cancers are ductal adenocarcinoma (PDAC). Extensive communication between tumour cells other cell types in microenvironment have been identified which regulate hallmarks during tumorigenesis via secretory factors extracellular vesicles (EVs). The EV-capsuled not only facilitate growth locally, but also enter circulation reach distant organs construct a pre-metastatic niche. In this review, we delineate key derived EVs that mediate different processes. Also, highlight related crosstalk with stem cells/cancer-initiating (CSC/CIC), subpopulation can efficiently metastasize resist currently used chemotherapies. Lastly, discuss potential early antitumour therapeutic strategies.

Language: Английский

Citations

49

Small extracellular vesicles (exosomes) and their cargo in pancreatic cancer: Key roles in the hallmarks of cancer DOI
Lily M. Channon, Victoria M. Tyma, Zhihong Xu

et al.

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Journal Year: 2022, Volume and Issue: 1877(3), P. 188728 - 188728

Published: April 3, 2022

Language: Английский

Citations

37